86 results
424B5
SEEL
Seelos Therapeutics Inc
30 Nov 23
Prospectus supplement for primary offering
4:58pm
and hire additional personnel in order to successfully administer and manage our clinical trials and other studies as planned, which may result in delays … agencies could hinder their ability to hire and retain key leadership and other personnel, properly administer drug innovation, or prevent our
424B5
SEEL
Seelos Therapeutics Inc
28 Nov 23
Prospectus supplement for primary offering
4:06pm
and hire additional personnel in order to successfully administer and manage our clinical trials and other studies as planned, which may result in delays … agencies could hinder their ability to hire and retain key leadership and other personnel, properly administer drug innovation, or prevent our product
424B5
SEEL
Seelos Therapeutics Inc
25 Sep 23
Prospectus supplement for primary offering
6:02am
is limited, we will need to train our existing personnel and hire additional personnel in order to successfully administer and manage our clinical trials … .
Changes in government funding for the FDA and other government agencies could hinder their ability to hire and retain key leadership and other personnel
424B5
fi1qed7j
12 May 22
Prospectus supplement for primary offering
8:30am
8-K
EX-10.2
m9qwkkzbipaoraan
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
8-K
EX-1.1
avtlemm csu1ks
21 May 21
Seelos Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
12:00am
424B5
tlwqsume
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
ylkd736q07nuz8b
19 May 21
Prospectus supplement for primary offering
4:08pm